KASAI Kenji
,
ABE Ryouetsu
,
WAKABAYASHI Masanori
,
NAKAMURA Kazuyoshi
,
SAWATANI Satoshi
,
WAKABAYASHI Tsunemichi
The spectrum of bone disease in end-stage renal failure is changing, but secondary hyperparathyroidism is still a troublesome complication. The vitamin D3 analog, maxacalcitol, has reduced calcemic ac …
J-STAGE